These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 28235515)

  • 1. Case report: Neuromuscular block induced by rocuronium following sugammadex administration.
    Askin T; Unver S; Oguz D; Kutay K
    J Clin Anesth; 2017 Feb; 37():166-167. PubMed ID: 28235515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
    Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
    J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.
    Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H
    J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.
    Kadoi Y; Hoshi H; Nishida A; Saito S
    J Anesth; 2011 Dec; 25(6):855-9. PubMed ID: 21947754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
    Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
    BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Sugammadex in an octagenerian with Myaesthenia Gravis undergoing emergency laporotomy.
    Shah D; Dharmarajah A
    J Clin Anesth; 2017 Feb; 37():109-110. PubMed ID: 28235495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.
    Groudine SB; Soto R; Lien C; Drover D; Roberts K
    Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block.
    Buonanno P; Laiola A; Palumbo C; Spinelli G; Servillo G; Di Minno RM; Cafiero T; Di Iorio C
    Anesth Analg; 2016 Jun; 122(6):1826-30. PubMed ID: 27028777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
    Fabregat López J; Porta Vila G; Martin-Flores M
    Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
    Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
    Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.